Monthly injections of ranibizumab improved reading speed in patients with macular edema secondary to retinal vein occlusion, according to a study.
The analysis was derived from the 789 patients with branch or central retinal vein occlusion who took part in the multicenter, double-masked phase 3 BRAVO and CRUISE trials.
Sham treatments were administered to 132 BRAVO patients and 130 CRUISE patients; intravitreal injections of Lucentis 0.3 mg (ranibizumab, Genentech) were administered to 134 BRAVO patients and 132 CRUISE patients; and intravitreal injections of ranibizumab 0.5 mg were administered to 131 BRAVO patients and 130 CRUISE patients.
Full Story »
Personalize your page!
Register for Healio to get content tailored to your specialty and areas of interest.
It’s FREE and only takes one minute.